Vicarious Surgical (RBOT) Total Current Liabilities (2020 - 2025)
Vicarious Surgical's (RBOT) quarterly Total Current Liabilities came in at $3.9 million in Q4 2025, down 49.08% year-on-year from $7.7 million in Q4 2024, and up 22.92% on a QoQ basis from $3.2 million in Q3 2025.
Vicarious Surgical (RBOT) Total Current Liabilities (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has 6 years of Total Current Liabilities data on file, last reported at $3.9 million in Q4 2025.
- On a quarterly basis, Total Current Liabilities fell 49.08% year-over-year to $3.9 million in Q4 2025; TTM through Dec 2025 was $3.9 million, a 49.08% decrease from a year earlier, with the FY2025 full-year figure at $3.9 million, down 49.08% from the prior year.
- Total Current Liabilities for Q4 2025 stood at $3.9 million, up from $3.2 million in the prior quarter.
- Over the last five years, Total Current Liabilities for RBOT reached as high as $11.7 million in Q3 2022 and fell as low as $1.5 million in Q1 2021.
- Historically, Total Current Liabilities has averaged $6.2 million across 5 years, with a median of $6.8 million in 2022.
- Across the five-year window, Total Current Liabilities surged 2244.22% in 2021 and plunged 63.08% in 2025, its largest moves.
- Year by year, Total Current Liabilities stood at $6.2 million in 2021, then soared by 34.4% to $8.4 million in 2022, then dropped by 13.26% to $7.3 million in 2023, then grew by 5.32% to $7.7 million in 2024, then plunged by 49.08% to $3.9 million in 2025.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $3.9 million in Q4 2025, $3.2 million in Q3 2025, and $5.1 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | Vicarious Surgical | 654,984.55 | -9.14 Mn | - | 3.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.90 Mn |
| Sep 30, 2025 | 3.18 Mn |
| Jun 30, 2025 | 5.10 Mn |
| Mar 31, 2025 | 7.86 Mn |
| Dec 31, 2024 | 7.67 Mn |
| Sep 30, 2024 | 8.60 Mn |
| Jun 30, 2024 | 7.18 Mn |
| Mar 31, 2024 | 5.08 Mn |
| Dec 31, 2023 | 7.28 Mn |
| Sep 30, 2023 | 7.80 Mn |
| Jun 30, 2023 | 7.49 Mn |
| Mar 31, 2023 | 6.67 Mn |
| Dec 31, 2022 | 8.39 Mn |
| Sep 30, 2022 | 11.68 Mn |
| Jun 30, 2022 | 6.89 Mn |
| Mar 31, 2022 | 6.39 Mn |
| Dec 31, 2021 | 6.25 Mn |
| Sep 30, 2021 | 3.11 Mn |
| Jun 30, 2021 | 2.17 Mn |
| Mar 31, 2021 | 1.51 Mn |